# Medifontis

**Canonical:** https://apis.io/providers/medifontis/  
**Website:** https://www.medifontis.com  
**APIs profiled:** 1

Medifontis provides a US drug database API that aggregates FDA NDC directory, Drugs@FDA, DailyMed, RxNorm, UNII substances, and FDA animal drugs into a single RESTful service. The API offers searchable endpoints by name, NDC, RxCUI, application number, SPL ID, and more, with daily updates and licensed source data, enabling developers to integrate comprehensive drug information into their applications.

## Kin Score — 29.5 / 100 (thin)

Scored 2026-10-31 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 66.1 |
| Contract Quality | 0.0 |
| Contract Governance | 18.2 |
| Operational Transparency | 21.1 |
| Developer Ergonomics | 50.0 |
| Access Clarity | 34.2 |

Regulatory layer — **Health**: 19.5 (matched via tags).

## Agent readiness — 6.8 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | derived |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | bearer |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | documented |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## APIs (1)

- **Medifontis API** — Country-scoped search over official medicine sources via the Medifontis API.

## Agentic access (1)

- **Medifontis Agentic Access** — 1 operation

## Security (2)

- **Medifontis Authentication** — 2 schemes
- **Medifontis Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Healthcare, API, FDA, Drugs

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/medifontis/). Scores are computed from the provider's own public artifacts under a published rubric.